Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia

被引:220
|
作者
Garcia, JM
Garcia-Touza, M
Hijazi, RA
Taffet, G
Epner, D
Mann, D
Smith, RG
Cunningham, GR
Marcelli, M
机构
[1] Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Med, Div Endocrinol Diabet & Metab, Houston, TX 77030 USA
[3] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA
来源
关键词
D O I
10.1210/jc.2004-1788
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Anorexia and weight loss are negative prognostic factors in patients with cancer. Although total ghrelin levels are increased in energy-negative states, levels of the biologically active octanoylated ghrelin and the anorexigenic peptide YY (PYY) have not been reported in patients with cancer-induced cachexia. We hypothesized that abnormal ghrelin and/or PYY levels contribute to cancer-induced cachexia. We evaluated 21 patients with cancer-induced cachexia; 24 cancer patients without cachexia; and 23 age-, sex-, race-, and BMI-matched subjects without cancer. Active ghrelin levels and the active to total ghrelin ratio were significantly increased in subjects with cancer-induced cachexia, compared with cancer and noncancer controls. PYY levels were similar among groups. Appetite measured by a visual analog scale was not increased in subjects with cachexia. The increase in active ghrelin levels is likely to be a compensatory response to weight loss. Cachexia may be a state of ghrelin resistance because appetite does not correlate with ghrelin levels. Changes in the active to total ghrelin ratio suggest that a mechanism other than increased secretion must be responsible for the increase in active ghrelin levels. PYY is unlikely to play an important role in cancer-induced cachexia.
引用
收藏
页码:2920 / 2926
页数:7
相关论文
共 50 条
  • [21] Ghrelin, adiponectin and leptin in cancer cachexia
    Wolf, I
    Sadetzki, S
    Kanety, H
    Kundel, Y
    Pariente, C
    Oberman, B
    Catane, R
    Kaufman, B
    Shimon, I
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 757S - 757S
  • [22] Active ghrelin levels in women with polycystic ovary syndrome
    Ferrero, S
    HORMONE AND METABOLIC RESEARCH, 2004, 36 (09) : 654 - 654
  • [23] Active ghrelin levels during fetal life and childhood
    Ferrero, S
    JOURNAL OF PEDIATRICS, 2004, 145 (06): : 862 - 862
  • [24] Decreased active, total and altered active to total ghrelin ratio in normal weight women with the more severe form of polycystic ovary syndrome
    Panidis, Dimitrios
    Asteriadis, Chrisostomos
    Georgopoulos, Neoklis A.
    Katsikis, Ilias
    Zournatzi, Vassiliki
    Karkanaki, Artemis
    Saltamavros, Alexandros D.
    Decavalas, George
    Diamanti-Kandarakis, Evanthia
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2010, 149 (02) : 170 - 174
  • [25] Relation of ghrelin, obestatin levels and ghrelin/ obestatin ratio with asthma
    Kizilirmak, Deniz
    Bozkurt, Bulent
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [26] Ghrelin attenuates burn-induced cachexia
    Balasubramaniam, A
    Joshi, R
    Su, C
    Friend, LA
    James, JH
    BIOPOLYMERS, 2005, 80 (04) : 559 - 559
  • [27] Ghrelin attenuates burn-induced cachexia
    Balasubramaniam, Ambikaipakan
    Joshi, Rashika
    Su, Chunhua
    Friend, Lou Ann
    James, James H.
    UNDERSTANDING BIOLOGY USING PEPTIDES, 2006, : 419 - +
  • [28] Growth hormone treatment modulates active ghrelin levels in rats
    Haddad, Haytham
    Mroueh, Mohamad
    Faour, Wissam H.
    Daher, Costantine
    ENDOCRINE RESEARCH, 2014, 39 (01) : 39 - 43
  • [29] Ghrelin as a Promising Therapeutic Option for Cancer Cachexia
    Khatib, Mahalaqua Nazli
    Gaidhane, Abhay
    Gaidhane, Shilpa
    Quazi Syed, Zahiruddin
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 48 (05) : 2172 - 2188
  • [30] Prokinetics and ghrelin for the management of cancer cachexia syndrome
    Malik, Jimi S.
    Yennurajalingam, Sriram
    ANNALS OF PALLIATIVE MEDICINE, 2019, 8 (01) : 80 - 85